Skip to main content
A scary good deal on trusted journalism
Get full digital access to globeandmail.com
$0.99
per week for 24 weeks SAVE OVER $140
OFFER ENDS OCTOBER 31
A scary good deal on trusted journalism
$0.99
per week
for 24 weeks
SAVE OVER $140
OFFER ENDS OCTOBER 31
// //

Fsd Pharma Inc Cl B NASDAQ: HUGE-Q

Today's Change
Volume
Real-Time Last Update Last Sale Cboe BZX Real-Time

Today's Trading

Day Low 1.5000
Day High 1.5400
Open:1.5100
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

FEATURE-EMPTY
Description
FSD Pharma Inc. produces medical cannabis primarily in Canada. The company focuses on the development of indoor pharmaceutical grade cannabis; research and development of cannabinoid-based treatments for central nervous system disorders. FSD Pharma Inc. is based in Seattle, Washington.

Fundamentals

Market Capitalization, $K
Shares Outstanding, K
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research.

No rating

StockCalc

What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.

ValuEngine

A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.

Latest Press Releases

KCSA Psychedelics Virtual Investor Conference Presentations Available for On-Demand Viewing
- PR Newswire - PRF - Mon Oct 18, 7:35AM CDT
PR Newswire - PRF - CMTX
Mon Oct 18, 7:35AM CDT
/PRNewswire/ --  in partnership with  today announced the presentations from the KCSA Psychedelics Virtual Investor Conference are now available for on-demand viewing.
FSD Pharma to Present at the KCSA Psychedelics Virtual Investor Conference on October 13th
- PR Newswire - PRF - Wed Oct 13, 7:00AM CDT
PR Newswire - PRF - CMTX
Wed Oct 13, 7:00AM CDT
/PRNewswire/ -- FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) ("" or the ""), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, is pleased to announce that , Interim CEO of FSD Pharma, and Dr. Lakshmi P. Kotra, CEO of FSD's wholly-owned subsidiary Lucid Psycheceuticals, will participate in the KCSA Psychedelics Investor Conference to be held at on .
InvestmentPitch Media Video Discusses FSD Pharma's Closing of its acquisition of Canadian Specialty Psychedelic Pharmaceutical Company Lucid Psycheceuticals - Video Available on Investmentpitch.com
- Newsfile Corp - Wed Sep 22, 2:06AM CDT
Newsfile Corp - CMTX
Wed Sep 22, 2:06AM CDT
Vancouver, British Columbia--(Newsfile Corp. - September 22, 2021) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9A), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions in legal psychedelics and medical cannabis, has closed its acquisition of Lucid Psycheceuticals. Founded in 2020, Lucid Psycheceuticals (), a Canadian-based specialty psychedelic pharmaceutical company, is developing novel molecules and combinations with the goal of addressing Total Brain Health and targeting some of the most challenging neurodegenerative diseases, such as Multiple Sclerosis, Alzheimer's disease and Parkinson's disease.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 1.4000 +8.67% increase
on 10/18/21
Period Open:1.5600
Price movement based on the high, low and last over the given period.
1.7000 -10.51% decrease
on 09/27/21
-0.0386 (-2.47%) decrease
since 09/21/21
3-Month 1.4000 +8.67% increase
on 10/18/21
Period Open:1.5900
Price movement based on the high, low and last over the given period.
1.9400 -21.58% decrease
on 08/25/21
-0.0686 (-4.31%) decrease
since 07/21/21
52-Week 1.2800 +18.86% increase
on 11/13/20
Period Open:1.9400
Price movement based on the high, low and last over the given period.
4.4400 -65.73% decrease
on 02/11/21
-0.4186 (-21.58%) decrease
since 10/21/20

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2021.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

© 2021 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies